Rheumatoid Arthritis
📧 Sign up to get email alerts when something new happens for Rheumatoid Arthritis.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2021-07-15FDA Approved: DICLOFENAC SODIUM/MISOPROSTOL DICLOFENAC-SODIUM-MISOPROSTOL — Original Application (Micro Labs Limited)
FDA approved the original application for a generic fixed-dose combination of diclofenac sodium and misoprostol from Micro Labs Limited.
-
CLINICAL_TRIALS trial_result · 2021-07-09Clinical Trial Update: Long-term Efficacy, Safety and Tolerability of ACZ885 in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 clinical trial update on long-term efficacy, safety, and tolerability of ACZ885 in patients with rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Genicular Nerve Block in Rheuamtoid Arthritis [Phase 4]
Phase 4 clinical trial investigating genicular nerve block for pain and joint function in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Vitamin D as a Key Player in Rheumatoid Arthritis [Phase 3]
A Phase 3 clinical trial evaluating vitamin D as a key modulator in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS withdrawal · 2021-06-23Clinical Trial Update: Comparison of the Effect of Etoricoxib and Diclofenac on Early Morning Activity in Rheumatoid Arthritis (RA) [Phase 4]
A Phase 4 trial comparing etoricoxib and diclofenac in rheumatoid arthritis has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: (C2013-0302) Safety and Efficacy of Escalating Doses of SAN-300 in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 trial evaluating escalating doses of SAN-300 in rheumatoid arthritis completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-21Clinical Trial Update: A Dose Response Study of E6011 in Participants With Rheumatoid Arthritis Inadequately Responding to Methotrexate [Phase 2]
Phase 2 clinical trial update for E6011 in rheumatoid arthritis patients inadequately responding to methotrexate has completed with posted r…
-
FDA approval · 2021-06-17FDA Approved: INFLECTRA — Supplemental Application (Pfizer Laboratories Div Pfizer Inc)
FDA approves a supplemental application for INFLECTRA (infliximab-dyyb) from Pfizer Laboratories Div Pfizer Inc, marking FDA action on a bio…
-
CLINICAL_TRIALS trial_result · 2021-06-15Clinical Trial Update: The Role of Tofacitinib in Steroid Withdrawal in Rheumatoid Arthritis [Phase 4]
Phase 4 trial investigating the role of tofacitinib in enabling steroid withdrawal for rheumatoid arthritis.
-
FDA approval · 2021-06-14FDA Approved: TREXALL — Supplemental Application (Teva Women's Health, Inc.)
The FDA approved a supplemental application for TREXALL (methotrexate) filed by Teva Women's Health, Inc.
-
CLINICAL_TRIALS trial_result · 2021-06-14Clinical Trial Update: Study to Evaluate Efficacy, Safety and Tolerability of JTE-051 in Subjects With Active Rheumatoid Arthritis [Phase 2]
A Phase 2 trial evaluating the efficacy, safety, and tolerability of JTE-051 in active rheumatoid arthritis has completed with posted result…
-
CLINICAL_TRIALS trial_result · 2021-06-10Clinical Trial Update: Comparison of Disease Modifying Antirheumatic Drugs Therapy in Patients With RA Failing Methotrexate Monotherapy [Phase 3]
Phase 3 trial comparing disease-modifying antirheumatic drugs in patients with rheumatoid arthritis who failed methotrexate monotherapy; stu…
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis [Phase 1, Phase 2]
Phase 1/2 trial evaluating safety and efficacy of efavaleukin alfa in active rheumatoid arthritis; study terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-04Clinical Trial Update: OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis [NA]
Clinical trial on using digital activity trackers to improve physical activity in inflammatory arthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy [Phase 4]
Phase 4 clinical trial comparing eupatilin and rebamipide for prevention of gastroenteropathy, sponsored by Seoul National University Borama…
-
CLINICAL_TRIALS trial_result · 2021-05-06Clinical Trial Update: Relationship Between T LYmphocytes Depletion and Clinical Response to RITUXimab in Rheumatoid Arthritis (LYRITUX) [Phase 3]
Phase 3 trial update examining the relationship between T lymphocyte depletion and clinical response to Rituximab in rheumatoid arthritis.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: A Phase 2 Study to Evaluate the Safety and Efficacy of YRA-1909 in Patients With Rheumatoid Arthritis [Phase 2]
Phase 2 study evaluating safety and efficacy of YRA-1909 in rheumatoid arthritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-03Clinical Trial Update: A Study to Investigate the Safety and Efficacy of ABBV-105 Alone or in Combination With Upadacitinib (ABBV-599 Combination) in Participants With Active Rheumatoid Arthritis [Phase 2]
A Phase 2 clinical trial investigating ABBV-105 alone or with Upadacitinib (ABBV-599) in active rheumatoid arthritis has completed with resu…
-
FDA approval · 2021-04-30FDA Approved: SULINDAC — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for sulindac from Sun Pharmaceutical Industries, Inc., authorizing changes to its labeling and/o…
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Evaluation of the Efficacy and Safety of Two Dosing Regimens of Olokizumab (OKZ), Compared to Placebo and Adalimumab, in Subjects With Rheumatoid Arthritis (RA) Who Are Taking Methotrexate But Have Active Disease [Phase 3]
Phase 3 trial comparing two dosing regimens of olokizumab (OKZ) to placebo and adalimumab in methotrexate-treated rheumatoid arthritis with …
-
CLINICAL_TRIALS trial_result · 2021-04-30Clinical Trial Update: Comparative Analysis of Outcomes Among Patients Treated With Xeljanz vs Biologics
A completed clinical trial comparing outcomes of Xeljanz with biologics in patients with rheumatoid arthritis.
-
FDA approval · 2021-04-29FDA Approved: ETODOLAC — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Etodolac (Apotex Corp.), approving a generic version of etodolac under an ANDA.
-
FDA approval · 2021-04-29FDA Approved: NABUMETONE — Supplemental Application (Chartwell RX, LLC)
FDA approves a supplemental application for nabumetone submitted by Chartwell RX, LLC. Nabumetone is an NSAID used for pain relief in condit…
-
FDA approval · 2021-04-28FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
The FDA approved a supplemental application for tolmetin sodium submitted by Atland Pharmaceuticals, LLC, resulting in updated labeling for …
-
FDA approval · 2021-04-28FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)
The FDA has approved a supplemental application for INDOCIN (indomethacin) by Zyla Life Sciences US LLC.